Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Raw Materials (2020 - 2025)

Beauty Health (SKIN) has disclosed Raw Materials for 6 consecutive years, with $18.5 million as the latest value for Q4 2025.

  • Quarterly Raw Materials fell 28.72% to $18.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Dec 2025, down 28.72% year-over-year, with the annual reading at $18.5 million for FY2025, 28.72% down from the prior year.
  • Raw Materials for Q4 2025 was $18.5 million at Beauty Health, down from $23.0 million in the prior quarter.
  • The five-year high for Raw Materials was $40.0 million in Q1 2023, with the low at $11.7 million in Q3 2021.
  • Average Raw Materials over 5 years is $24.0 million, with a median of $23.8 million recorded in 2023.
  • The sharpest move saw Raw Materials surged 219.14% in 2022, then plummeted 40.57% in 2024.
  • Over 5 years, Raw Materials stood at $12.0 million in 2021, then soared by 219.14% to $38.4 million in 2022, then tumbled by 36.4% to $24.4 million in 2023, then rose by 6.61% to $26.0 million in 2024, then decreased by 28.72% to $18.5 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $18.5 million, $23.0 million, and $23.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.